Correction: LabTech launches MicroStreak in US
Friday, 13 June, 2008
In our online story LabTech launches MicroStreak in the US on June 11, we incorrectly stated that LabTech Systems had received royalties from sales.
The company is anticipating royalties but they have not been received yet. LabTech Systems has instead received licence payments of $4.9 million to date from licencee bioMerieux, and is entitled to receive up to a total of $11.2 million.
The original story has been corrected. We apologise for the error.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
